These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Preliminary study of the therapeutic action and tolerance of niflumic acid in pediatric otorhinolaryngology]. Traissac L; Roche JC Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):317-21. PubMed ID: 897412 [No Abstract] [Full Text] [Related]
5. [Experiences with Mediitan in the otorhinolaryngological practice of the specialist]. Kuhnke J Landarzt; 1967 Aug; 43(23):1122-3. PubMed ID: 5590172 [No Abstract] [Full Text] [Related]
6. [Importance of the use of the beta-morpholino-ethylic ester of niflumic acid in the treatment of non-surgical ORL infections in children. Apropos of 21 cases]. Lauwers JP Rev Laryngol Otol Rhinol (Bord); 1979; 100(7-8):509-12. PubMed ID: 531386 [No Abstract] [Full Text] [Related]
7. [Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone]. Tarantino V; Stura M; Cremonesi G Minerva Pediatr; 1985 Oct; 37(20):827-32. PubMed ID: 3912657 [No Abstract] [Full Text] [Related]
8. [Niflumic acid in maxillofacial injuries and in sequela of surgical interventions in O.R.L]. Decroix G; Pilliaert JM Lille Med; 1972 Feb; 17():Suppl 2:156-9. PubMed ID: 5034394 [No Abstract] [Full Text] [Related]
9. [Niflumic acid (UP 83) in otorhinolaryngology. Clincal study of 75 cases]. Bouche J; Bruker J Ann Otolaryngol Chir Cervicofac; 1968 Jun; 85(4):361-8. PubMed ID: 5706080 [No Abstract] [Full Text] [Related]
11. [Ampicillin aerosol in otorhinolaryngologic diseases]. Caroggio A Minerva Otorinolaringol; 1970; 20(2):50-5. PubMed ID: 5489965 [No Abstract] [Full Text] [Related]
12. [Treatment of certain otorhinolaryngologic diseases by intravenous administration of oxyglucocycline]. Pluzhnikov MS; Gevorkian EA Vestn Otorinolaringol; 1976; (1):47-9. PubMed ID: 1274061 [No Abstract] [Full Text] [Related]
13. [Clinical analysis of the use of tetracycline laurylsulphate in otorhinolaryngologic diseases]. Pulido R Acta Otorinolaryngol Iber Am; 1968; 19(2):163-73. PubMed ID: 5721522 [No Abstract] [Full Text] [Related]
15. [Opipramol in the otorhinolaryngologic functional disorders]. Sancho Alvarez A Acta Otorinolaryngol Iber Am; 1969; 20(1):43-58. PubMed ID: 5791862 [No Abstract] [Full Text] [Related]
16. [Hemostatic action of estrogens in ORL. Trials of Premarine]. Hadj-Djilani A Rev Med Suisse Romande; 1966 Mar; 86(3):216-24. PubMed ID: 4286236 [No Abstract] [Full Text] [Related]
17. [Test of topical therapeutics in current otorhinolaryngologic practice]. Wayoff M Ann Otolaryngol Chir Cervicofac; 1974 Sep; 91(9):539-41. PubMed ID: 4469769 [No Abstract] [Full Text] [Related]
18. [Clinical experiences in the use of lincomycin in otorhinolaryngologic infections]. Merhy AS; Goribar MH Prensa Med Mex; 1969; 34(1):73-6. PubMed ID: 5787508 [No Abstract] [Full Text] [Related]
19. [Use of abboticine in otorhinolaryngology]. Mounier-Kuhn P; Haguenauer JP; Bouchayer M J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Mar; 18(3):191-3. PubMed ID: 4245686 [No Abstract] [Full Text] [Related]
20. [Pain control in otorhinolaryngologic treatment using Dolo-Buscopan]. Franz H Munch Med Wochenschr; 1966 May; 108(21):1166-8. PubMed ID: 6014173 [No Abstract] [Full Text] [Related] [Next] [New Search]